Correction: Outcomes among newly diagnosed AL amyloidosis patients with a very high NT-proBNP: implications for trial design.
Vaxman I, Kumar SK, Buadi F, Lacy MQ, Dingli D, Hwa Y, Fonder A, Hobbs M, Hayman S, Kourelis T, Warsame R, Muchtar E, Leung N, Kapoor P, Grogan M, Go R, Lin Y, Gonsalves W, Siddiqui M, Kyle RA, Rajkumar SV, Gertz MA, Dispenzieri A.
Vaxman I, et al. Among authors: lin y.
Leukemia. 2024 Jun 17. doi: 10.1038/s41375-024-02311-w. Online ahead of print.
Leukemia. 2024.
PMID: 38886493
No abstract available.